Results

Total Results: 425 records

Showing results for "laboratory".

121. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - City), and Pastorus Pharma, LLC, of Green River, WY, in collaboration with Shin Nippon Biomedical Laboratories … Tokyo: Shin Nippon Biomedical Laboratories, Ltd. [accessed 2013 Mar 11]. [3 p].

122. Kidney-Stone-Prevention Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_executive.pdf
     March 01, 2013 - Clinical guidelines recommend that patients who experience kidney stones undergo a laboratory evaluation … composition and possibly of urine and blood biochemistries.30 Unclear, however, is whether pretreatment laboratory … stone recurrence and other clinical health outcomes, or whether treatment tailored to pretreatment laboratory … In sum, available data did not support the value of any of these individual baseline laboratory measures … Studies also should report the laboratory and radiographic testing participants undergo, including their

123. Nephropathy-Contrast-Induced Executive-2016 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/nephropathy-contrast-induced_executive-2016.pdf
     January 01, 2016 - study, we focused on the main outcome of interest, CIN, an outcome that is objectively measured by laboratory … versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory

124. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-diff-infections_research-protocol.pdf
     May 24, 2010 - Comparators: Diagnostic tests: cell cytotoxicity assay with or without stool culture (excludes in-house laboratory … Studies which used in-house laboratory cell cytotoxicity tests will be excluded.

125. Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/antiplatelet-treatment/research

126. Impact of Healthcare Worker Safety and Wellness: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/worker-safety-wellness-protocol.pdf
     October 26, 2024 - contact as well as those who work within healthcare in administrative or other supportive roles, such as laboratory … who do not interact with patients, environmental service workers, sterile service personnel, medical laboratory … Cancer risk from professional exposure in staff working in cardiac catheterization laboratory: insights

127. Prioritization and Selection of Harms for Inclusion in Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-selection-harms-systematic-reviews.pdf
     February 01, 2018 - should give priority to final (mortality, morbidity, quality of life, or function) over intermediate (laboratory … Routinely Include Serious or Common and Bothersome Harms (II) Intermediate outcomes such as the changes in laboratory

128. Disposition of Comments Report for Recurrent Nephrolithiasis in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stone-prevention_disposition-comments.pdf
     July 26, 2012 - revised report, we added a future research recommendation that future RCTs consider reporting “the laboratory … This latter phrase has been used to refer a biochemical laboratory abnormality, which is distinct from … measures to We raised this issue in the Introduction of the main report as follows: “Clinicians may use laboratory … Based on this reviewer’s feedback, we modified our statement slightly: Clinicians may use laboratory

129. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
     March 01, 2017 - Yet, the relationship between these laboratory or imaging findings and measures of cognition are inconsistent … and it is not clear whether some of these laboratory or imaging findings are causes of or caused by … with greater sensitivity than is possible with behavior-based testing or interviews, a variety of laboratory

130. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
     March 01, 2017 - Yet, the relationship between these laboratory or imaging findings and measures of cognition are inconsistent … and it is not clear whether some of these laboratory or imaging findings are causes of or caused by … with greater sensitivity than is possible with behavior-based testing or interviews, a variety of laboratory

131. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
     September 25, 2013 - Some laboratories still use a consistent platelet count for LTA measurements, so the platelet count … The reviewers provide a detailed description of the laboratory procedures and factors affecting analytic … Therefore, there is no standardization of LTA measurements between laboratories Paul A. … By triggering PGE1 receptor‐mediated The reviewers’ provide a detailed description of the laboratory … Note that the same situation appears in many laboratory tests; in all these cases the latent variable

132. Diagnosis and Management of Gout: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
     January 01, 2017 - The role of clinical algorithms (which often draw upon clinical signs, symptoms, and laboratory tests

133. Treatment of Hepatitis C Virus Infection in Adults: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-future_research.pdf
     April 01, 2013 - Adverse events, including serious adverse events and grade 3-4 laboratory abnormalities. … Adverse events, including serious adverse events and grade 3-4 laboratory abnormalities. … Adverse events, including serious adverse events and grade 3-4 laboratory abnormalities. … events Occurrence of drug-related adverse events as assessed by the investigator Occurrence of laboratory … test abnormalities Central tendency and changes from baseline in laboratory test values over time

134. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
     November 01, 2009 - For example, the Harvard Cyclotron Laboratory has been succeeded by the Northeast Proton Therapy Center … , and the Lawrence Berkeley Laboratory has been succeeded by the University of California San Francisco … The table does not include two centers that are now inactive, namely the Lawrence Berkeley Laboratory … in California (succeeded by UCSF) and the Harvard Cyclotron Laboratory in Massachusetts (succeeded … beam therapy A single currently inactive facility (University of California, Lawrence Berkeley Laboratory

135. Vitamin-D-Calcium-Protocol-130611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
     September 13, 2013 - disease (beyond their roles in preventing acute deficiency states) and physicians’ increasing use of laboratory … are not strictly comparable with each other or with historical values.5,6 Evidence suggests current laboratory

136. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/administrative-data-validity_research.pdf
     January 01, 2007 - MPH of the validity of neutropenia diagnoses in Medicaid, the encounter diagnosis was verified by laboratory

137. PHS 398 (Rev. 9/04), Continuation Page (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/upenn-final-report-2005-certs-ce-supplement.pdf
     January 01, 2005 - MPH of the validity of neutropenia diagnoses in Medicaid, the encounter diagnosis was verified by laboratory

138. Glaucoma-Treatment-Appendices-11-5-10-2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
     October 27, 2009 - DISPOSABLE ENDO-OCULAR PROBE SE 4/13/1988 AESCULAP-MEDITEC NORTH AMERICA MEDITEC LINK SE 6/17/1998 ALCON LABORATORIES … MULTIPLE Registered n/a HOOD LABORATORIES KRUPIN EYE VALVE W/SCLERAL BUCKLE SE 1/24/1989 HOOD LABORATORIES

139. Renal-Function Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-function_research-protocol.pdf
     June 13, 2013 - National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics … National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics … National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin

140. Horizon Scanning Protocol and Operations Manual January 2013 Revision (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
     August 01, 2013 - Is this a laboratory-developed test (LDT)? … expressed intent to create and market a commercial test kit in the United States that can be acquired by laboratories … health, technology, the arts, humanities, social sciences and business X X X X X X American Laboratory … Covers current and future trends in clinical laboratory medicine X X X A-7 Table 1. … Publishes clinical studies translational laboratory findings, mini- reviews and controversial topics